Skip to main content
Top
Published in: BMC Neurology 1/2019

Open Access 01-12-2019 | Melanoma | Case report

Primary diffuse meningeal melanomatosis – a rare form of meningeal melanoma: case report

Authors: Tomasz Garbacz, Michał Osuchowski, Halina Bartosik-Psujek

Published in: BMC Neurology | Issue 1/2019

Login to get access

Abstract

Background

Meningeal melanomatosis is a rare type of central nervous system neoplasm (with incidence ranging between 3 and 5%) that develops in the course of malignant melanoma. In a small percentage of cases, meningeal melanomatosis may develop without a primary focus. It affects the leptomeninx. The clinical activity of the disease is uncharacteristic, with a number of neurological symptoms developing over weeks or months.

Case presentation

A 45-year-old male patient presented with consciousness disturbance, cognitive dysfunctions, seizures and progressive paresis. None of the examinations performed, including cerebrospinal fluid examination, neuroimaging and biopsy of the leptomeninges, permitted us to establish a diagnosis during the patient’s hospital stay. The diagnosis of meningeal melanomatosis was established after an autopsy had been carried out.

Conclusions

In the absence of unequivocal test results, it is also worth taking into account the primary changes in the leptomeninx, including those caused by melanoma.
Literature
2.
go back to reference Zadro I, Brinar VV, Barun B, Ozretic´ D, Pazanin L, Grahovac G,et al. Primary diffuse meningeal melanomatosis. Neurologist 2010;16:117–119.CrossRef Zadro I, Brinar VV, Barun B, Ozretic´ D, Pazanin L, Grahovac G,et al. Primary diffuse meningeal melanomatosis. Neurologist 2010;16:117–119.CrossRef
3.
go back to reference Wadasadawala T, Trivedi S, Gupta T, Epari S, Jalali R. Thediagnostic dilemma of primary central nervous system melanoma. J Clin Neurosci. 2010;17:1014–7.CrossRef Wadasadawala T, Trivedi S, Gupta T, Epari S, Jalali R. Thediagnostic dilemma of primary central nervous system melanoma. J Clin Neurosci. 2010;17:1014–7.CrossRef
6.
go back to reference Harstad L., Hess K., Groves M. (2008) Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Society for Neuro-Oncology. Harstad L., Hess K., Groves M. (2008) Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Society for Neuro-Oncology.
7.
go back to reference Hong Je Lee, Byeong-Cheol Ahn, Seong Wook Hwang, Suk Kyong Cho, Hae Won Kim, et al. (2013) F-18 Fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal Melanomatosis, Korean J Radiol kjronline.org 14(2), Mar/Apr 2013. Hong Je Lee, Byeong-Cheol Ahn, Seong Wook Hwang, Suk Kyong Cho, Hae Won Kim, et al. (2013) F-18 Fluorodeoxyglucose PET/CT and post hoc PET/MRI in a case of primary meningeal Melanomatosis, Korean J Radiol kjronline.org 14(2), Mar/Apr 2013.
8.
go back to reference Seehusen DA, Reeves MM, Fomin DA. American family physician: cerebrospinal fluid analysis; 2003. p. 1103–8. Seehusen DA, Reeves MM, Fomin DA. American family physician: cerebrospinal fluid analysis; 2003. p. 1103–8.
11.
go back to reference Douglas JG, Margolin K. (2002) the treatment of brain metastases from malignant melanoma. Semin Oncol. 2002;29(5):518–24.CrossRef Douglas JG, Margolin K. (2002) the treatment of brain metastases from malignant melanoma. Semin Oncol. 2002;29(5):518–24.CrossRef
Metadata
Title
Primary diffuse meningeal melanomatosis – a rare form of meningeal melanoma: case report
Authors
Tomasz Garbacz
Michał Osuchowski
Halina Bartosik-Psujek
Publication date
01-12-2019
Publisher
BioMed Central
Keywords
Melanoma
Melanoma
Published in
BMC Neurology / Issue 1/2019
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-019-1460-x

Other articles of this Issue 1/2019

BMC Neurology 1/2019 Go to the issue